X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Pfizer with Elder Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs ELDER PHARMA - Comparison Results

PFIZER    Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER ELDER PHARMA PFIZER/
ELDER PHARMA
 
P/E (TTM) x 34.5 -0.2 - View Chart
P/BV x 5.1 0.1 5,031.0% View Chart
Dividend Yield % 0.7 0.0 -  

Financials

 PFIZER   ELDER PHARMA
EQUITY SHARE DATA
    PFIZER
Mar-18
ELDER PHARMA
Jun-14
PFIZER/
ELDER PHARMA
5-Yr Chart
Click to enlarge
High Rs2,365380 622.4%   
Low Rs1,625188 864.4%   
Sales per share (Unadj.) Rs430.3491.2 87.6%  
Earnings per share (Unadj.) Rs78.7-3.2 -2,473.7%  
Cash flow per share (Unadj.) Rs93.214.4 646.7%  
Dividends per share (Unadj.) Rs20.000-  
Dividend yield (eoy) %1.00-  
Book value per share (Unadj.) Rs586.5376.5 155.8%  
Shares outstanding (eoy) m45.7520.54 222.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.60.6 801.9%   
Avg P/E ratio x25.3-89.3 -28.4%  
P/CF ratio (eoy) x21.419.7 108.6%  
Price / Book Value ratio x3.40.8 451.0%  
Dividend payout %25.40-   
Avg Mkt Cap Rs m91,2715,833 1,564.6%   
No. of employees `0002.6NA-   
Total wages/salary Rs m3,1432,179 144.2%   
Avg. sales/employee Rs Th7,484.8NM-  
Avg. wages/employee Rs Th1,195.0NM-  
Avg. net profit/employee Rs Th1,369.1NM-  
INCOME DATA
Net Sales Rs m19,68510,089 195.1%  
Other income Rs m1,143257 445.4%   
Total revenues Rs m20,82810,346 201.3%   
Gross profit Rs m5,003-792 -631.8%  
Depreciation Rs m663361 183.4%   
Interest Rs m42,756 0.2%   
Profit before tax Rs m5,479-3,653 -150.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m03,713 0.0%   
Tax Rs m1,878125 1,500.9%   
Profit after tax Rs m3,601-65 -5,509.9%  
Gross profit margin %25.4-7.8 -323.8%  
Effective tax rate %34.3-3.4 -1,000.7%   
Net profit margin %18.3-0.6 -2,823.9%  
BALANCE SHEET DATA
Current assets Rs m24,1679,240 261.6%   
Current liabilities Rs m9,5449,998 95.5%   
Net working cap to sales %74.3-7.5 -989.1%  
Current ratio x2.50.9 274.0%  
Inventory Days Days5546 119.0%  
Debtors Days Days2960 47.9%  
Net fixed assets Rs m9,51410,124 94.0%   
Share capital Rs m458206 222.4%   
"Free" reserves Rs m26,3755,582 472.5%   
Net worth Rs m26,8327,734 347.0%   
Long term debt Rs m254,889 0.5%   
Total assets Rs m36,90022,882 161.3%  
Interest coverage x1,305.5-0.3 -401,347.4%   
Debt to equity ratio x00.6 0.1%  
Sales to assets ratio x0.50.4 121.0%   
Return on assets %9.811.8 83.1%  
Return on equity %13.4-0.8 -1,588.1%  
Return on capital %20.422.3 91.5%  
Exports to sales %03.0 0.0%   
Imports to sales %00.4 0.0%   
Exports (fob) Rs mNA307 0.0%   
Imports (cif) Rs mNA43 0.0%   
Fx inflow Rs m22307 7.3%   
Fx outflow Rs m1,489125 1,188.1%   
Net fx Rs m-1,466181 -808.8%   
CASH FLOW
From Operations Rs m3,31811,754 28.2%  
From Investments Rs m-2,383-561 425.2%  
From Financial Activity Rs m-1,104-6,762 16.3%  
Net Cashflow Rs m-1694,432 -3.8%  

Share Holding

Indian Promoters % 0.0 39.6 -  
Foreign collaborators % 63.9 0.0 -  
Indian inst/Mut Fund % 7.5 7.5 100.0%  
FIIs % 4.9 16.8 29.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 36.1 65.7%  
Shareholders   85,207 16,479 517.1%  
Pledged promoter(s) holding % 0.0 77.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   CADILA HEALTHCARE  TTK HEALTHCARE  SHASUN PHARMA  DISHMAN PHARMA  J.B.CHEMICALS  

Compare PFIZER With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades Weak; FMCG Stocks Drag(12:30 pm)

Stock markets in India are trading in negative territory weighed by fast-moving consumer goods (FMCG) stocks.

Related Views on News

PFIZER Announces Quarterly Results (1QFY19); Net Profit Up 60.6% (Quarterly Result Update)

Aug 3, 2018 | Updated on Aug 3, 2018

For the quarter ended June 2018, PFIZER has posted a net profit of Rs 918 m (up 60.6% YoY). Sales on the other hand came in at Rs 5 bn (up 18.4% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (4QFY18); Net Profit Up 53.6% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, PFIZER has posted a net profit of Rs 1 bn (up 53.6% YoY). Sales on the other hand came in at Rs 5 bn (up 14.7% YoY). Read on for a complete analysis of PFIZER's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

My First Pharma Stock Recommendation!(The 5 Minute Wrapup)

Sep 21, 2018

This company has not only created a niche in the pharma space, it has done so profitably.

Oh Yes! This is the Best Trading Opportunity in Two Decades(Profit Hunter)

Sep 21, 2018

Getting ready to buy stocks once this correction is over? This private sector bank should be on a profit hunter's radar.

Outperformance of Strong Established Brands in the Indian Stock market(Chart Of The Day)

Sep 14, 2018

Strong Well established Indian Brands have comfortably outperformed the index in the decade post the global financial crisis.

How IL&FS Rating Downgrade Will Impact Your Mutual Funds...(Outside View)

Sep 17, 2018

PersonalFN explains the impact of IL&FS rating downgrade on mutual funds.

How To Identify Sachin Tendulkars And Rahul Dravids Of Tomorrow For Your Mutual Fund Portfolio(Outside View)

Sep 19, 2018

PersonalFN explains how to pick 'undiscovered' or lesser-known mutual funds that are capable of generating big gains for you.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Sep 26, 2018 01:49 PM

TRACK PFIZER

PFIZER - FULFORD INDIA COMPARISON

COMPARE PFIZER WITH

MARKET STATS